Current Management of Patients with Ductal Carcinoma-in-Situ-Reference-Cited by-同舟云学术

Current Management of Patients with Ductal Carcinoma-in-Situ

Published:1997-04-01 Issue:2 Volume:2 Page:76-82
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Chabner Elizabeth¹,Schnitt Stuart²,Harris Jay¹

Affiliation:

1. Joint Center For Radiation Therapy, Harvard Medical School, Boston, Massachusetts, USA

2. Beth Israel Hospital Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA

Abstract

Abstract Because of the wider use of screening mammography, ductal carcinoma-in-situ, or DCIS, once rare, is now diagnosed with increasing frequency. Important questions remain unresolved regarding the natural history, classification, and management of DCIS. Many physicians have assumed that DCIS is diffuse and regularly progresses to invasive cancer; therefore, they routinely recommend mastectomy. However, as we learn more about this lesion, it is now clear that in many cases the lesion is focal in extent, “premalignant,” and curable with local procedures short of mastectomy. In this review, we describe the current state of knowledge regarding the presentation, pathology, natural history, and management of DCIS.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2-2-76

Reference47 articles.

1. Projections of the breast cancer burden to US women: 1990-2000;Kessler;Prev Med,1991

2. Incidence of and treatment for ductal carcinoma in situ of the breast;Ernster;JAMA,1996

3. Needle localized mammographic lesions. Results and evolving treatment strategy;Alexander;Arch Surg,1990

4. Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsy;Morrow;Arch Surg,1994

5. Non-palpable breast lesions: diagnosis with slightly over penetrated screen-film mammography and hook wire directed biopsy in 1014 cases;Silverstein;Radiology,1989

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASO Author’s Reflections: Are Genomic Assays Informing the Management of Ductal Carcinoma in situ as They Have for Invasive Breast Cancer?;Annals of Surgical Oncology;2021-02-01

2. Use of the Twelve-Gene Recurrence Score for Ductal Carcinoma in Situ and Its Influence on Receipt of Adjuvant Radiation and Hormonal Therapy;Annals of Surgical Oncology;2021-01-18

3. On the birth of breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2001-11

4. Classification of ductal carcinoma in situ: Striving for clinical relevance in the era of breast conserving therapy;Human Pathology;1997-08

5. Mechanisms of Apoptosis Resistance In Breast Cancer;Breast Cancer and Molecular Medicine